Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-319
Closed -$24.1K 2318
2026
Q1
$24.1K Hold
319
0.01% 390
2025
Q4
$23.8K Hold
319
0.01% 366
2025
Q3
$21.5K Buy
319
+39
+14% +$2.59K 0.01% 377
2025
Q2
$18.2K Buy
280
+173
+162% +$10.4K 0.01% 393
2025
Q1
$6.61K Sell
107
-10
-9% -$663 ﹤0.01% 652
2024
Q4
$8.44K Hold
117
﹤0.01% 682
2024
Q3
$9.53K Buy
117
+10
+9% +$800 ﹤0.01% 586
2024
Q2
$7.95K Hold
107
﹤0.01% 458
2024
Q1
$8.34K Hold
107
0.01% 438
2023
Q4
$7.64K Buy
+107
New +$7.45K 0.01% 480

Other funds holding HOLX

Fortitude Family Office's HOLX Position: Q2 2026 in Review

Fortitude Family Office sold out of Hologic (HOLX) in Q2 2026, closing a stake of 319 shares — an estimated $24.1K sold.

Fortitude Family Office first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $24.1K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Fortitude Family Office reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 319 Hologic shares in Q2 2026, an estimated $24.1K.
  • Fortitude Family Office first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Fortitude Family Office's Hologic position peaked at $24.1K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.